Inspire Medical Systems (STU:2DR) Total Current Assets: €490.3 Mil (As of Mar. 2026)


STU:2DR Inspire Medical Systems Inc STU:2DR
56 GF Score
Price €40.80
GF Value €188.24
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Inspire Medical Systems Total Current Assets?

Inspire Medical Systems STU:2DR -0.49% 56 Total Current Assets is €490.3 Mil as of Mar. 2026. GuruFocus rates STU:2DR with a GF Score™ of 56/100 and a GF Value™ of €188.24 (Possible Value Trap). The stock has 7 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Inspire Medical Systems's total current assets for the quarter that ended in Mar. 2026 was €490.3 Mil.


Inspire Medical Systems  (STU:2DR) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Inspire Medical Systems's Liquidation Value for the quarter that ended in Mar. 2026 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=245.516-102.966+0.75 * 90.901+0.5 * 143.793
=282.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inspire Medical Systems Total Current Assets Related Terms


Inspire Medical Systems Total Current Assets Historical Data

* Premium members only.

The historical data trend for Inspire Medical Systems's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inspire Medical Systems Total Current Assets Chart

Inspire Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 237.66 500.35 544.46 602.42 498.44

Inspire Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 528.80 496.96 499.69 498.44 490.30
STU:2DR
56GF Score
Inspire Medical Systems Inc STU:2DR
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspire Medical Systems Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Inspire Medical Systems's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Inspire Medical Systems's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of €490.3 Mil mean?
Inspire Medical Systems (STU:2DR) has a Total Current Assets of €490.3 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Inspire Medical Systems and its competitors.
Is Inspire Medical Systems' Total Current Assets too high?
Inspire Medical Systems' current Total Current Assets is €490.3 Mil. Overall, Inspire Medical Systems has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' Total Current Assets compare to ENOV and PRCT?
Inspire Medical Systems' Total Current Assets of €490.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Medical Devices & Instruments company?
A good Total Current Assets depends on the Medical Devices & Instruments industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Inspire Medical Systems and its competitors. Inspire Medical Systems's current Total Current Assets is €490.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (STU:2DR) is currently considered Possible Value Trap. The stock's GF Value™ is €188.24, compared to a current price of €40.80 — trading 78.3% below its estimated fair value. The current Total Current Assets is €490.3 Mil. Inspire Medical Systems' overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For Inspire Medical Systems (STU:2DR), the current Total Current Assets is €490.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspire Medical Systems (STU:2DR) Overvalued in 2026?

Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued. The current stock price of €40.80 is trading 78.3% below its estimated GF Value™ of €188.24. GuruFocus considers Inspire Medical Systems to be Possible Value Trap.

Key valuation signals for STU:2DR:

  • Total Current Assets: €490.3 Mil
  • GF Value™: €188.24 vs. price of €40.80 (78.3% below fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the STU:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Inspire Medical Systems Business Description

Other Exchanges INSP:USA
Address 5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
56GF Score

Get the complete analysis for STU:2DR

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€40.80
Price
€188.24
GF Value